As of 4:00pm ET
| -0.05 / -1.32%|
The 1 analysts offering 12-month price forecasts for CASI Pharmaceuticals Inc have a median target of 4.50, with a high estimate of 4.50 and a low estimate of 4.50. The median estimate represents a +20.64% increase from the last price of 3.73.
The current consensus among 1 polled investment analysts is to Buy stock in CASI Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.